EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning

Preksha Bhagchandani, Stephan A Ramos, Bianca Rodriguez, Xueying Gu, Shiva Pathak, Yuqi Zhou, Yujin Moon, Nadia Nourin, Charles A Chang, Jessica Poyser, Brenda J Velasco, Weichen Zhao und 7 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci190034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Preksha Bhagchandani und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Diabetes Mellitus, Type 1, Islets of Langerhans Transplantation, Transplantation Conditioning. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIH Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mixed hematopoietic chimerism after allogeneic hematopoietic cell transplantation (HCT) promotes tolerance of transplanted donor-matched solid organs, corrects autoimmunity, and could transform therapeutic strategies for autoimmune type 1 diabetes (T1D). However, development of nontoxic bone marrow conditioning protocols is needed to expand clinical use. We developed a chemotherapy-free, nonmyeloablative (NMA) conditioning regimen that achieves mixed chimerism and allograft tolerance across MHC barriers in NOD mice. We obtained durable mixed hematopoietic chimerism in prediabetic NOD mice using anti–CD117 monoclonal antibody, T cell depleting antibodies, JAK1/2 inhibition, and low-dose total body irradiation prior to transplantation of MHC-mismatched B6 hematopoietic cells, preventing diabetes in 100% of chimeric NOD:B6 mice. In overtly diabetic NOD mice, NMA conditioning followed by combined B6 HCT and islet transplantation durably corrected diabetes in 100% of chimeric mice without chronic immunosuppression or graft-versus-host disease (GVHD). Chimeric mice remained immunocompetent, as assessed by blood count recovery and rejection of third-party allogeneic islets. Adoptive transfer studies and analysis of autoreactive T cells confirmed correction of autoimmunity. Analysis of chimeric NOD mice revealed central thymic deletion and peripheral tolerance mechanisms. Thus, with NMA conditioning and cell transplantation, we achieved durable hematopoietic chimerism without GVHD, promoted islet allograft tolerance, and reversed established T1D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationDiabetes Mellitus, Type 1Islets of Langerhans TransplantationTransplantation ConditioningProto-Oncogene Proteins c-kitAntibodies, MonoclonalAnimalsMiceMice, Inbred NODFemaleTransplantation ChimeraMice, Inbred C57BL

Stichwörter der Autor:innen

Autoimmune diseasesAutoimmunityBone marrow transplantationDiabetesEndocrinologyTransplantation

Substanzen

Proto-Oncogene Proteins c-kitAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Developmental Biology.
  • Division of Blood and Marrow Transplantation, Department of Medicine.
  • Stanford Diabetes Research Center, and.
  • Northern California Breakthrough T1D Center of Excellence, Stanford School of Medicine, Stanford, California, USA.

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIH Clinical Center
  • JDRF
  • Stanford Interdisciplinary Graduate Fellowship
  • Stanford Institute for Immunity, Transplantation and Infection
  • Reid Family
  • H. L. Snyder Medical Foundation

Zitieren

APA

Bhagchandani, P., Ramos, S. A., Rodriguez, B., Gu, X., Pathak, S., Zhou, Y., Moon, Y., Nourin, N., Chang, C. A., Poyser, J., Velasco, B. J., Zhao, W., Kwon, H. S., Rodriguez, R., Burgos, D. M., Miranda, M. A., Meyer, E., Shizuru, J. A., & Kim, S. K. (2026). Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning. Journal of Clinical Investigation. https://doi.org/10.1172/jci190034

Vancouver

Bhagchandani P, Ramos SA, Rodriguez B, Gu X, Pathak S, Zhou Y, et al. Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning. Journal of Clinical Investigation. 2026. doi:10.1172/jci190034

BibTeX
@article{Bhagchandani2026,
  author = {Bhagchandani, Preksha and Ramos, Stephan A and Rodriguez, Bianca and Gu, Xueying and Pathak, Shiva and Zhou, Yuqi and Moon, Yujin and Nourin, Nadia and Chang, Charles A and Poyser, Jessica and Velasco, Brenda J and Zhao, Weichen and Kwon, Hye-Sook and Rodriguez, Richard and Burgos, Diego M and Miranda, Mario A and Meyer, Everett and Shizuru, Judith A and Kim, Seung K},
  title = {Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci190034}
}
Kostenlos starten →